LUMIQ
"LUMIQ" is a word mark owned by AliveDx Suisse SA, filed at the EUIPO on June 3, 2025. It is registered and covers classes 1, 5, 9, 10, 42 and 44.
- Status
- Registered
- Filed
- June 3, 2025
- Registered
- June 25, 2026
- Expires
- June 3, 2035
- Application no.
- 019197264
- Registration no.
- 019197264
- Office
- EUIPO
- European Union Intellectual Property Office
- Mark type
- Word mark
- 6 classes
Who owns LUMIQ
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
AliveDx Suisse SA
Representative
Marks & Clerk LLP
Marks & Clerk LLP
What the mark covers
The products and services LUMIQ is filed for, grouped by Nice class.
Diagnostic preparations for scientific or research use provided as part of a kit; diagnostic reagents for scientific or research use; diagnostic substances, other than for medical use; test kits consisting of diagnostic preparations for scientific or research use; diagnostic products in kit form for test use; diagnostic testing materials, other than for medical use; diagnostic reagents and diagnostic reagents for analytical, scientific and industrial use; diagnostic assay preparation, namely, assays, for scientific, industrial and research purposes; testing reagents for scientific use; test reagents [other than for medical use]; reagents for use in analytical tests [other than for medical or veterinary purposes]; reagents for use in diagnostic tests [other than for medical or veterinary purposes]; testing reagents and other substances in kit form for use in analysing the functionality and accuracy of diagnostic instruments and assays; clinical diagnostics, other than for medical or veterinary use
Diagnostic preparations and materials for antigen typing, antibody identification and detection, disease screening, virology screening, autoimmune disease identification, testing and detection, autoantibody testing and detection; medical diagnostic reagents, namely in vitro diagnostic (IVD) reagents; clinical diagnostic reagents; reagents for use in diagnostic tests [for medical laboratory purposes not to be used for pharmaceutical purposes or treatments]; Diagnostic reagents derived from blood or in-vitro culture or tissue sections for medical diagnostic purposes; indirect immunofluorescence assays for medical diagnostic purpose based on single cells or tissue sections substrates for disease screening by antibodies search; assays for antigen typing, antibody identification and detection, disease screening, virology screening, autoimmune disease identification, testing and detection, autoantibody testing and detection; immunofluorescence assays for in-vitro testing for medical diagnostic purposes; diagnostic reagents for medical use; chemical reagents for medical diagnosis and analysis; diagnostic assay preparations in the nature of assays and substances in the nature of reagents for antibody and antigen screening and/or identification for clinical diagnostic and medical diagnostic use; medical diagnostic reagents and assays for testing of body fluids; medical diagnostic reagents for testing blood components for clinical use; medical diagnostic reagents for clinical and medical use, namely quality control reagents and calibrators for use in in vitro diagnostic tests; diagnostic reagents for virology screening for donor blood; medical diagnostic reagents for clinical use for autoimmunity and infectious diseases; medical diagnostic assays for diagnostics use for antibody or antigen screening and/or identification, disease screening; serum for use in testing and analysing the functionality and accuracy of diagnostic instruments and assays; sera and other matrices for use in testing and analysing the functionality and accuracy of diagnostic instruments and assays; testing reagents for medical use; chemical test reagents [medical]; chemical test reagents [medical] for antigen typing, antibody identification and detection, disease screening, virology screening, autoimmune disease identification, testing and detection, autoantibody testing and detection; all the aforesaid goods being in vitro diagnostic reagents and assay preparations for laboratory use, none being intended for therapeutic use; the aforesaid goods excluding pharmaceutical preparations and substances for the prevention or treatment of diseases
Scientific research and laboratory apparatus for diagnostic testing in the nature of antibody and antigen screening and/or identification, and disease screening; laboratory equipment, namely, substrates; testing apparatus for diagnostic purposes [other than medical]; diagnostic apparatus, not for medical purposes; research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids; computer software for use with diagnostic products for scientific or research use; computer software for use with diagnostic instruments; computer software for use in medical diagnostics; computer software for use in clinical diagnostics; computer software for use in diagnostic testing and analysis of medical samples; computer software for use in antigen typing, antibody identification and detection, disease screening, virology screening, autoimmune disease identification, testing and detection, autoantibody testing and detection, allergy testing, and food allergy testing; computer software for use with scientific research and laboratory apparatus, laboratory equipment and instrumentation; computer software for use with scientific research and laboratory apparatus, laboratory equipment and instrumentation for antigen typing, antibody identification and detection, disease screening, virology screening, autoimmune disease identification, testing and detection, autoantibody testing and detection, allergy testing, and food allergy testing; computer software for education and training in the field of diagnostic reagents, use of diagnostic reagents, diagnostics testing, clinical diagnostics, pharmaceutical and medical preparations, substances and vaccines for human use; computer software for education and training relating to medical research, medical diagnostic services, and laboratory services; computer software for education and training relating to antigen typing, antibody identification and detection, disease screening, virology screening, autoimmune disease identification, testing and detection, autoantibody testing and detection, allergy testing, and food allergy testing
Medical diagnostic testing instruments for autoimmunity and infectious diseases; testing instruments for medical diagnostic purposes; apparatus for carrying-out diagnostic tests for medical purposes; medical testing instruments; testing apparatus for medical purposes; medical diagnostic testing instruments for screening blood products; medical diagnostic testing instruments for antigen screening and/or identification; medical diagnostic testing instruments for antibody screening and/or identification; Medical testing instruments for in-vitro testing, namely glass slides coated with multiple substrates being tissue section or cell based substrates
Medical research services; medical research services relating to antigen typing, antibody identification and detection, disease screening, virology screening, autoimmune disease identification, testing and detection, autoantibody testing and detection, allergy testing, and food allergy testing; scientific testing services; laboratory testing services; immunology and virology laboratory services; immunology and virology laboratory services relating to antigen typing, antibody identification and detection, disease screening, virology screening, autoimmune disease identification, testing and detection, autoantibody testing and detection, allergy testing, and food allergy testing; software as a service [SaaS] featuring software for use with diagnostic products for scientific or research use; software as a service [SaaS] featuring software for use with diagnostic instruments; software as a service [SaaS] featuring software for use in medical diagnostics; software as a service [SaaS] featuring software for use in clinical diagnostics; software as a service [SaaS] featuring software for use in diagnostic testing and analysis of medical samples; software as a service [SaaS] featuring software for use in antigen typing, antibody identification and detection, disease screening, virology screening, autoimmune disease identification, testing and detection, autoantibody testing and detection, allergy testing, and food allergy testing; software as a service [SaaS] featuring software for use with scientific research and laboratory apparatus, laboratory equipment and instrumentation; software as a service [SaaS] featuring software for use with scientific research and laboratory apparatus, laboratory equipment and instrumentation for antigen typing, antibody identification and detection, disease screening, virology screening, autoimmune disease identification, testing and detection, autoantibody testing and detection, allergy testing, and food allergy testing; software as a service [SaaS] featuring software platforms for education and training in the field of diagnostic reagents, use of diagnostic reagents, diagnostics testing, clinical diagnostics, pharmaceutical and medical preparations, substances and vaccines for human use; software as a service [SaaS] featuring software platforms for education and training relating to medical research, medical diagnostic services, and laboratory services; software as a service [SaaS] featuring software platforms for education and training relating to antigen typing, antibody identification and detection, disease screening, virology screening, autoimmune disease identification, testing and detection, autoantibody testing and detection, allergy testing, and food allergy testing; design and development of diagnostic apparatus; research and development in the field of diagnostic preparations; development of testing methods; computer aided diagnostic testing services; quality control testing in relation to diagnostic techniques, processes and instruments, all for clinical medical use; information, advice and consultancy in relation to the aforesaid services
Medical diagnostic services; medical testing services; medical diagnostic and testing services in the field of antigen typing, antibody identification and detection, disease screening, virology screening, autoimmune disease identification, testing and detection, autoantibody testing and detection, allergy testing, and food allergy testing; in-vitro diagnostic services; clinical chemistry services; bloodbank services; virology screening services for donor blood; haemastasis services in the nature of medical analysis services; information and advisory services relating to disease screening; information, advice and consultancy in relation to the aforesaid services; Medical advisory services; medical advisory services relating to antigen typing, antibody identification and detection, disease screening, virology screening, autoimmune disease identification, testing and detection, autoantibody testing and detection, allergy testing, and food allergy testing
What has happened so far
Steps recorded by the EUIPO, newest first.
- Bulletin 2026/119 Section B.2
- Opposition 003252577 — WITHDRAWN
- Bulletin 2025/177 Section A.1
Oppositions and cancellations
Proceedings recorded against this mark by the EUIPO. Reported as recorded, not legal advice.
About LUMIQ
Who owns the trademark "LUMIQ"?
The EUIPO trademark "LUMIQ" (application 019197264) is owned by AliveDx Suisse SA.
What is the status of "LUMIQ"?
Its status at the EUIPO is: registered.
When was "LUMIQ" registered?
It was registered on June 25, 2026 and is due to expire on June 3, 2035.
Get this data via the API
Everything on this page comes from the Signa API. Pull LUMIQ and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019d48cd-ba82-7210-94af-d3ec303ed556
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019d48cd-ba82-7210-94af-d3ec303ed556",
"object": "trademark",
"mark_text": "LUMIQ",
"status": {
"primary": "active",
"stage": "registered"
},
"office_code": "EM",
"application_number": "019197264",
"filing_date": "2025-06-03",
"nice_classes": [
1,
5,
9,
10,
42,
44
],
"owners": [
{
"name": "AliveDx Suisse SA",
"entity_id": "ent_019ebb4c-3883-75cf-ba2e-3e786895aec4"
}
]
}